Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
Top Cited Papers
Open Access
- 8 October 2012
- journal article
- review article
- Published by Wiley in The Anatomical Record
- Vol. 295 (11), 1837-1850
- https://doi.org/10.1002/ar.22578
Abstract
This review introduces the pathology of aminoglycoside antibiotic and the cisplatin chemotherapy classes of drugs, discusses oxidative stress in the inner ear as a primary trigger for cell damage, and delineates the ensuing cell death pathways. Among potentially ototoxic (damaging the inner ear) therapeutics, the platinum‐based anticancer drugs and the aminoglycoside antibiotics are of critical clinical importance. Both drugs cause sensorineural hearing loss in patients, a side effect that can be reproduced in experimental animals. Hearing loss is reflected primarily in damage to outer hair cells, beginning in the basal turn of the cochlea. In addition, aminoglycosides might affect the vestibular system while cisplatin seems to have a much lower likelihood to do so. Finally, based on an understanding the mechanisms of ototoxicity pharmaceutical ways of protection of the cochlea are presented. Anat Rec, 2012.Keywords
This publication has 147 references indexed in Scilit:
- Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycinProceedings of the National Academy of Sciences of the United States of America, 2012
- Activation of apoptotic pathways in the absence of cell death in an inner-ear immortomouse cell lineHearing Research, 2012
- TRPA1-Mediated Accumulation of Aminoglycosides in Mouse Cochlear Outer Hair CellsJournal of the Association for Research in Otolaryngology, 2011
- Fine Tuning Gene Expression: The EpigenomeSeminars in Nephrology, 2010
- Transtympanic Administration of Short Interfering (si)RNA for the NOX3 Isoform of NADPH Oxidase Protects Against Cisplatin-Induced Hearing Loss in the RatAntioxidants and Redox Signaling, 2010
- Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop MutationsJournal of Medicinal Chemistry, 2009
- Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicityProceedings of the National Academy of Sciences of the United States of America, 2008
- A catechol- O -methyltransferase that is essential for auditory function in mice and humansProceedings of the National Academy of Sciences of the United States of America, 2008
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005